These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 9316394)

  • 21. MHC II and the endocytic pathway: regulation by invariant chain.
    Landsverk OJ; Bakke O; Gregers TF
    Scand J Immunol; 2009 Sep; 70(3):184-93. PubMed ID: 19703008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Class II HLA-peptide binding prediction using structural principles.
    Mohanapriya A; Lulu S; Kayathri R; Kangueane P
    Hum Immunol; 2009 Mar; 70(3):159-69. PubMed ID: 19187794
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intercellular exchange of class II MHC complexes: ultrastructural localization and functional presentation of adsorbed I-A/peptide complexes.
    Patel DM; Dudek RW; Mannie MD
    Cell Immunol; 2001 Nov; 214(1):21-34. PubMed ID: 11902826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The exogenous pathway for antigen presentation on major histocompatibility complex class II and CD1 molecules.
    Watts C
    Nat Immunol; 2004 Jul; 5(7):685-92. PubMed ID: 15224094
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antigen presentation to naive CD4 T cells in the lymph node.
    Itano AA; Jenkins MK
    Nat Immunol; 2003 Aug; 4(8):733-9. PubMed ID: 12888794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unexpected reactivities of T cells selected by a single MHC-peptide ligand.
    Singh N; Van Kaer L
    J Immunol; 1999 Oct; 163(7):3583-91. PubMed ID: 10490950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of APC in the selection of immunodominant T cell epitopes.
    Ma C; Whiteley PE; Cameron PM; Freed DC; Pressey A; Chen SL; Garni-Wagner B; Fang C; Zaller DM; Wicker LS; Blum JS
    J Immunol; 1999 Dec; 163(12):6413-23. PubMed ID: 10586031
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficient presentation of known HLA class II-restricted MAGE-A3 epitopes by dendritic cells electroporated with messenger RNA encoding an invariant chain with genetic exchange of class II-associated invariant chain peptide.
    Bonehill A; Heirman C; Tuyaerts S; Michiels A; Zhang Y; van der Bruggen P; Thielemans K
    Cancer Res; 2003 Sep; 63(17):5587-94. PubMed ID: 14500399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antigen unfolding and disulfide reduction in antigen presenting cells.
    Jensen PE
    Semin Immunol; 1995 Dec; 7(6):347-53. PubMed ID: 8775460
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Major histocompatibility class II molecules prevent destructive processing of exogenous peptides at the cell surface of macrophages for presentation to CD4 T cells.
    von Delwig A; Musson JA; Gray J; McKie N; Robinson JH
    Immunology; 2005 Feb; 114(2):194-203. PubMed ID: 15667564
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exogenously provided peptides fail to complex with intracellular class II molecules for presentation by antigen-presenting cells.
    Monji T; Pious D
    J Immunol; 1997 Apr; 158(7):3155-64. PubMed ID: 9120269
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhancing tumor vaccines: catalyzing MHC class II peptide exchange.
    Croft NP; Purcell AW
    Expert Rev Vaccines; 2010 Feb; 9(2):129-32. PubMed ID: 20109023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. (E)-alkene and ethylene isosteres substantially alter the hydrogen-bonding network in class II MHC A(q)/glycopeptide complexes and affect T-cell recognition.
    Andersson IE; Batsalova T; Haag S; Dzhambazov B; Holmdahl R; Kihlberg J; Linusson A
    J Am Chem Soc; 2011 Sep; 133(36):14368-78. PubMed ID: 21766871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced binding of peptide antigen to purified class II major histocompatibility glycoproteins at acidic pH.
    Jensen PE
    J Exp Med; 1991 Nov; 174(5):1111-20. PubMed ID: 1940792
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A central role for HSC70 in regulating antigen trafficking and MHC class II presentation.
    Deffit SN; Blum JS
    Mol Immunol; 2015 Dec; 68(2 Pt A):85-8. PubMed ID: 25953005
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanistic understanding and significance of small peptides interaction with MHC class II molecules for therapeutic applications.
    Afridi S; Hoessli DC; Hameed MW
    Immunol Rev; 2016 Jul; 272(1):151-68. PubMed ID: 27319349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanism of action of antimalarial drugs: inhibition of antigen processing and presentation.
    Fox RI; Kang HI
    Lupus; 1993 Feb; 2 Suppl 1():S9-12. PubMed ID: 8097945
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanisms of antigen presentation.
    Jensen PE
    Clin Chem Lab Med; 1999 Mar; 37(3):179-86. PubMed ID: 10353458
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peptides bound to major histocompatibility complex molecules.
    Maffei A; Harris PE
    Peptides; 1998; 19(1):179-98. PubMed ID: 9437752
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perspectives: protein structure. Class-conscious TCR?
    Wilson IA
    Science; 1999 Dec; 286(5446):1867-8. PubMed ID: 10610577
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.